Free Trial

SOPHiA GENETICS (SOPH) News Today

SOPHiA GENETICS logo
$3.12 0.00 (0.00%)
As of 04:00 PM Eastern
Morgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS (SOPH) Gets a Buy from BTIG
SOPHiA GENETICS SA stock logo
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 64.4%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 61,800 shares, a growth of 64.4% from the February 13th total of 37,600 shares. Based on an average daily volume of 74,500 shares, the short-interest ratio is currently 0.8 days. Approximately 0.1% of the shares of the company are short sold.
SOPHiA GENETICS (SOPH) Receives a Buy from BTIG
Sophia Genetics price target lowered to $5 from $6 at BTIG
SOPHiA GENETICS (SOPH) Gets a Buy from RBC Capital
Sophia Genetics sees FY25 revenue $72M-$76M, consensus $74.51M
Craig-Hallum Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
SOPHiA GENETICS SA stock logo
SOPHiA GENETICS (NASDAQ:SOPH) Issues Earnings Results
SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.23) EPS for the quarter, meeting the consensus estimate of ($0.23). SOPHiA GENETICS had a negative return on equity of 55.06% and a negative net margin of 110.71%.
SOPHiA GENETICS SA stock logo
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Growth in Short Interest
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 37,600 shares, an increase of 89.9% from the January 31st total of 19,800 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 69,500 shares, the days-to-cover ratio is presently 0.5 days.
SOPHiA GENETICS SA stock logo
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday
SOPHiA GENETICS (NASDAQ:SOPH) will be releasing earnings before the market opens on Tuesday, March 4. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667363)
Sophia Genetics announces adoption of MSK-Access
SOPHiA GENETICS SA stock logo
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Drop in Short Interest
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 19,800 shares, a drop of 34.0% from the January 15th total of 30,000 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 53,500 shares, the short-interest ratio is currently 0.4 days.
SOPHiA GENETICS SA stock logo
SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% - Here's Why
SOPHiA GENETICS (NASDAQ:SOPH) Trading Down 4.4% - Here's Why
RBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)
SOPHiA GENETICS SA stock logo
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 31,400 shares, a decrease of 15.1% from the December 15th total of 37,000 shares. Based on an average daily trading volume, of 25,600 shares, the short-interest ratio is presently 1.2 days. Currently, 0.1% of the shares of the stock are short sold.
Morgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS SA stock logo
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 37,000 shares, a growth of 38.6% from the November 30th total of 26,700 shares. Based on an average daily volume of 24,300 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.1% of the company's stock are short sold.
Craig-Hallum bullish on Sophia Genetics, initiates with a Buy
SOPHiA GENETICS SA stock logo
Craig Hallum Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)
Craig Hallum started coverage on shares of SOPHiA GENETICS in a research note on Wednesday. They set a "buy" rating and a $11.00 price objective on the stock.
SOPHiA GENETICS SA stock logo
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 52.7%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 26,700 shares, a decline of 52.7% from the November 15th total of 56,500 shares. Based on an average trading volume of 26,800 shares, the short-interest ratio is presently 1.0 days. Approximately 0.1% of the shares of the stock are sold short.
SOPHiA GENETICS (SOPH) Receives a Buy from RBC Capital
Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)
Q3 2024 Sophia Genetics SA Earnings Call
SOPHiA GENETICS Q3 2024 Financial Highlights
SOPHiA GENETICS Faces Financial Challenges Amid Losses
Remove Ads
Get SOPHiA GENETICS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter.

SOPH Media Mentions By Week

SOPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SOPH
News Sentiment

0.25

0.68

Average
Medical
News Sentiment

SOPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SOPH Articles
This Week

2

2

SOPH Articles
Average Week

Remove Ads
Get SOPHiA GENETICS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SOPH) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners